The price of medicines in Jordan: the cost of trade-based intellectual property RB Abbott, R Bader, L Bajjali, TA ElSamen, T Obeidat, H Sboul, ... Journal of Generic Medicines 9 (2), 75-85, 2012 | 51 | 2012 |
Melatonin increases intracellular calcium in the liver, muscle, white adipose tissues and pancreas of diabetic obese rats A Agil, EK Elmahallawy, JM Rodriguez-Ferrer, A Adem, SM Bastaki, ... Food & function 6 (8), 2671-2678, 2015 | 40 | 2015 |
One-year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan I Al-Abbadi, A Qawwas, M Jaafreh, T Abosamen, M Saket Clinical therapeutics 31 (6), 1335-1344, 2009 | 40 | 2009 |
Implications of external price referencing of pharmaceuticals in Middle East countries Z Kaló, I Alabbadi, OG Al Ahdab, M Alowayesh, M Elmahdawy, ... Expert review of pharmacoeconomics & outcomes research 15 (6), 993-998, 2015 | 39 | 2015 |
Patterns of antiepileptic drugs use in epileptic pediatric patients in Jordan A Albsoul-Younes, L Gharaibeh, AA Murtaja, A Masri, I Alabbadi, ... Neurosciences Journal 21 (3), 264-267, 2016 | 19 | 2016 |
Multi-indication pharmacotherapeutic multicriteria decision analytic model for the comparative formulary inclusion of proton pump inhibitors in Qatar D Al-Badriyeh, I Alabbadi, M Fahey, A Al-Khal, M Zaidan Clinical therapeutics 38 (5), 1158-1173, 2016 | 19 | 2016 |
Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework I Alabbadi, G Crealey, K Turner, T Rafferty, L Keenan, P Murray, ... Pharmacy world & science 32, 43-51, 2010 | 19 | 2010 |
The role of clinical pharmacist in initiation and/or dose adjustment of insulin therapy in diabetic patients in outpatient clinic in Jordan S Abuloha, I Alabbadi, A Albsoul-Younes, N Younes, A Zayed Jordan Journal of Pharmaceutical Sciences 9 (1), 2016 | 18 | 2016 |
Pharmacoeconomics education in WHO Eastern Mediterranean region Q Alefan, S AlImam, T Mukattash, N Mhaidat, I Alabbadi, K Rascati Currents in Pharmacy Teaching and Learning 7 (6), 819-825, 2015 | 18 | 2015 |
Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care K Chalkidou, J Lord, NA Obeidat, IA Alabbadi, AG Stanley, R Bader, ... International journal of technology assessment in health care 27 (2), 151-158, 2011 | 16 | 2011 |
Hospital unit costs in Jordan: insights from a country facing competing health demands and striving for universal health coverage EA Hammad, I Alabbadi, F Taissir, M Hajjwi, NM Obeidat, Q Alefan, ... Health Economics Review 12 (1), 11, 2022 | 14 | 2022 |
Implementation road map of health technology assessment in middle-income countries: the case of Jordan E Almomani, I Alabbadi, A Fasseeh, R Al-Qutob, E Al-Sharu, N Hayek, ... Value in Health Regional Issues 25, 126-134, 2021 | 14 | 2021 |
Investigating the effect of pharmaceutical companies’ gifts on doctors’ prescribing behavior in Jordan A Ghaith, H Aldmour, I Alabbadi European Journal of Social Sciences 36 (4), 528-536, 2013 | 14 | 2013 |
Pharmacy students' perceptions of the teaching evaluation process in Jordan I Al‐Abbadi, F Alkhateeb, N Khanfar, B Mujtaba, D Latif Education, Business and Society: Contemporary Middle Eastern Issues 2 (3 …, 2009 | 13 | 2009 |
Investigating the factors affecting doctor's prescribing behavior in Jordan: Antihypertensive drugs as an example E Abulhaj, AA ELSamen, I Alabbadi European Journal of Social Sciences 38 (3), 380-391, 2013 | 12 | 2013 |
Cost Impact of Purchasing Pharmaceuticals Jointly I Alabbadi Jordan Journal of Pharmaceutical Sciences 4 (2), 2011 | 10 | 2011 |
Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitors I Alabbadi, G Crealey, M Scott, S Baird, T Trouton, J Mairs, J McElnay Clinical drug investigation 26, 485-494, 2006 | 8 | 2006 |
Investigating the Effect of Syrian Refugees on the Pharmaceutical Sector in Jordan. A Daher, I Alabbadi Archives of Iranian Medicine (AIM) 20 (8), 2017 | 7 | 2017 |
Statin selection in Qatar based on multi-indication pharmacotherapeutic multi-criteria scoring model, and clinician preference D Al-Badriyeh, M Fahey, I Alabbadi, A Al-Khal, M Zaidan Clinical Therapeutics 37 (12), 2798-2810, 2015 | 7 | 2015 |
Pharmaceutical business and pharmaceutical industry: New tracks in pharmacy education initiated in Jordan I Alabbadi Jordan Journal of Pharmaceutical Sciences 8 (3), 2015 | 7 | 2015 |